Event: enhanced HCC-related survival in STAM mice, reduced the incidence of liver tumors, and prevented liver injury mechanism: inhibited the IRE1- XBP1-PHLD3A pathway. The gene discussed is XBP1; the disease is hepatocellular carcinoma.